{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T23:55:05Z","timestamp":1764374105595,"version":"3.46.0"},"reference-count":78,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tierarztl Prax Ausg K Kleintiere Heimtiere"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Die canine atopische Dermatitis (caD) ist eine genetisch bedingte,\n                    chronisch-entz\u00fcndliche Hautkrankheit, bei der Defekte der Hautbarriere,\n                    Allergensensibilisierung und mikrobielle Dysbiose eine Rolle spielen. Sie \u00e4u\u00dfert\n                    sich v.\u202fa. durch Juckreiz und tritt meist im jungen Alter zum ersten Mal auf.\n                    Die Diagnose erfolgt durch gr\u00fcndliche Anamneseerhebung, klinische Untersuchung\n                    und den Ausschluss von Differentialdiagnosen. Die Auswahl der Therapieoptionen\n                    zur Behandlung der caD ist von verschiedenen Faktoren abh\u00e4ngig und umfasst\n                    systemische und topische Medikamente zur Immunmodulation.<\/jats:p>\n                  <jats:p>Da die Krankheit eine erhebliche Belastung der Besitzer*innen mit sich bringen\n                    kann, ist eine umfassende, verst\u00e4ndliche und nachhaltige Aufkl\u00e4rung durch\n                    Tier\u00e4rzt*innen notwendig, um Betroffene besser in das Krankheitsmanagement\n                    einzubinden und langfristig zu entlasten.<\/jats:p>\n                  <jats:p>Die langfristige Behandlung der caninen atopischen Dermatitis erfordert eine hohe\n                    Therapietreue sowie ausreichende Gesundheitskompetenz der Tierbesitzer*innen, da\n                    sie die komplexen, oftmals aufw\u00e4ndigen topischen Behandlungen\n                    eigenverantwortlich anpassen und durchf\u00fchren m\u00fcssen. Gezielte Schulungen der\n                    betroffenen Besitzer*innen k\u00f6nnen das Verst\u00e4ndnis der Erkrankung, das\n                    Selbstmanagement und damit die Lebensqualit\u00e4t sowie den Behandlungserfolg\n                    deutlich verbessern.<\/jats:p>","DOI":"10.1055\/a-2712-9246","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T23:50:07Z","timestamp":1764373807000},"page":"338-349","source":"Crossref","is-referenced-by-count":0,"title":["Canine atopische Dermatitis"],"prefix":"10.1055","volume":"53","author":[{"given":"Viktoria A.","family":"Birner","sequence":"additional","affiliation":[{"name":"Kleintierklinik, LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf S.","family":"Mueller","sequence":"additional","affiliation":[{"name":"Kleintierklinik, LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0165-2427(01)00296-3","article-title":"The ACVD task force on canine atopic dermatitis (I): incidence and\n                    prevalence","volume":"81","author":"A Hillier","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/VMRR.S412570","article-title":"Canine Atopic Dermatitis: Prevalence, Impact, and Management Strategies","volume":"15","author":"Y Drechsler","year":"2024","journal-title":"Vet Med (Auckl)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s0165-2427(01)00346-4","article-title":"The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations\n                    of canine atopic dermatitis","volume":"81","author":"C E Griffin","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13671-020-00303-4","article-title":"Phenotypes of Canine Atopic Dermatitis","volume":"9","author":"M Eisenschenk","year":"2020","journal-title":"Current Dermatology Reports"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12917-015-0514-6","article-title":"Treatment of canine atopic dermatitis: 2015 updated guidelines from the\n                    International Committee on Allergic Diseases of Animals (ICADA)","volume":"11","author":"T Olivry","year":"2015","journal-title":"BMC Vet Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000370226","article-title":"The impact of atopic dermatitis on quality of life","volume":"66","author":"C Lifschitz","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-3164.2010.00899.x","article-title":"Impact of canine atopic dermatitis on the health-related quality of life of\n                    affected dogs and quality of life of their owners","volume":"21","author":"M Linek","year":"2010","journal-title":"Vet Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/vde.13183","article-title":"Introduction to the ICADA 2023 canine atopic dermatitis pathogenesis review\n                    articles and updated definition","volume":"35","author":"M C Eisenschenk","year":"2024","journal-title":"Vet Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/vde.12198","article-title":"Review: Role of genetics and the environment in the pathogenesis of canine\n                    atopic dermatitis","volume":"26","author":"P Bizikova","year":"2015","journal-title":"Vet Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1046\/j.1365-3164.2002.00285.x","article-title":"Canine atopic dermatitis: a retrospective study of 266 cases examined at the\n                    University of California, Davis, 1992\u20131998. Part I. Clinical features and\n                    allergy testing results","volume":"13","author":"G Zur","year":"2002","journal-title":"Vet Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12917-019-1880-2","article-title":"Critically appraised topic on adverse food reactions of companion animals (7):\n                    signalment and cutaneous manifestations of dogs and cats with adverse food\n                    reactions","volume":"15","author":"T Olivry","year":"2019","journal-title":"BMC Vet Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1365-3164.2007.00625.x","article-title":"Food for thought: pondering the relationship between canine atopic dermatitis\n                    and cutaneous adverse food reactions","volume":"18","author":"T Olivry","year":"2007","journal-title":"Vet Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci4030037","article-title":"Atopic Dermatitis in Animals and People: An Update and Comparative Review","volume":"4","author":"R Marsella","year":"2017","journal-title":"Vet Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12917-017-1142-0","article-title":"Critically appraised topic on adverse food reactions of companion animals (4):\n                    can we diagnose adverse food reactions in dogs and cats with in vivo or in vitro\n                    tests?","volume":"13","author":"R S Mueller","year":"2017","journal-title":"BMC Vet Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-3164.2010.00925.x","article-title":"Breed-associated phenotypes in canine atopic dermatitis","volume":"22","author":"S Wilhem","year":"2011","journal-title":"Vet Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2460\/javma.254.11.1291","article-title":"Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in\n                    dogs","volume":"254","author":"T J Nuttall","year":"2019","journal-title":"J Am Vet Med Assoc"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12917-015-0515-5","article-title":"Canine atopic dermatitis: detailed guidelines for diagnosis and allergen\n                    identification","volume":"11","author":"P Hensel","year":"2015","journal-title":"BMC Vet Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0165-2427(01)00312-9","article-title":"The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in\n                    clinical diagnosis","volume":"81","author":"D J DeBoer","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-3164.2009.00758.x","article-title":"A prospective study on the clinical features of chronic canine atopic dermatitis\n                    and its diagnosis","volume":"21","author":"C Favrot","year":"2010","journal-title":"Vet Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.yasa.2021.07.004","article-title":"Current Knowledge on Canine Atopic Dermatitis: Pathogenesis and Treatment","volume":"2","author":"C A Outerbridge","year":"2021","journal-title":"Adv Small Anim Care"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13601-018-0228-5","article-title":"Atopic dermatitis in cats and dogs: a difficult disease for animals and\n                    owners","volume":"8","author":"NK Y Gedon","year":"2018","journal-title":"Clin Transl Allergy"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1365-3164.2010.00889.x","article-title":"Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from\n                    the International Task Force on Canine Atopic Dermatitis","volume":"21","author":"T Olivry","year":"2010","journal-title":"Vet Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-3164.2012.01088.x","article-title":"A systematic review of randomized controlled trials for prevention or treatment\n                    of atopic dermatitis in dogs: 2008\u20132011 update","volume":"24","author":"T Olivry","year":"2013","journal-title":"Vet Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-3164.2005.00491.x","article-title":"A systematic review and meta-analysis of the efficacy and safety of cyclosporin\n                    for the treatment of atopic dermatitis in dogs","volume":"17","author":"J Steffan","year":"2006","journal-title":"Vet Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/vr.102471","article-title":"Life-long diseases need life-long treatment: long-term safety of ciclosporin in\n                    canine atopic dermatitis","volume":"174","author":"T Nuttall","year":"2014","journal-title":"Vet Rec"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/jvp.12101","article-title":"Oclacitinib (APOQUEL((R))) is a novel Janus kinase inhibitor with activity\n                    against cytokines involved in allergy","volume":"37","author":"A J Gonzales","year":"2014","journal-title":"J Vet Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12917-025-04579-1","article-title":"Safety of ilunocitinib tablets (Zenrelia) after once daily oral administration\n                    in dogs","volume":"21","author":"E A Kuntz","year":"2025","journal-title":"BMC Vet Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12016-010-8239-6","article-title":"A modular view of cytokine networks in atopic dermatitis","volume":"41","author":"I Carmi-Levy","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/vde.12047","article-title":"Efficacy and safety of oclacitinib for the control of pruritus and associated\n                    skin lesions in dogs with canine allergic dermatitis","volume":"24","author":"S B Cosgrove","year":"2013","journal-title":"Vet Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/vde.13344.","article-title":"Efficacy and field safety of ilunocitinib for the control of atopic dermatitis\n                    in client-owned dogs: A multicentre, double-masked, randomised,\n                    placebo-controlled clinical trial","author":"S Forster","year":"2025","journal-title":"Vet Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1111\/vde.12186","article-title":"A blinded, randomized clinical trial comparing the efficacy and safety of\n                    oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned\n                    dogs","volume":"26","author":"P R Little","year":"2015","journal-title":"Vet Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/vde.13319","article-title":"Comparative efficacy and safety of ilunocitinib and oclacitinib for the control\n                    of pruritus and associated skin lesions in dogs with atopic dermatitis","volume":"36","author":"S Forster","year":"2025","journal-title":"Vet Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.alit.2022.04.003","article-title":"Peripheral itch sensitization in atopic dermatitis","volume":"71","author":"M Tominaga","year":"2022","journal-title":"Allergol Int"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/vde.12376","article-title":"A blinded, randomized, placebo-controlled, dose determination trial of\n                    lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in\n                    client owned dogs with atopic dermatitis","volume":"27","author":"G M Michels","year":"2016","journal-title":"Vet Dermatol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/vde.12364","article-title":"A blinded, randomized, placebo-controlled trial of the safety of lokivetmab\n                    (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in\n                    client-owned dogs with atopic dermatitis","volume":"27","author":"G M Michels","year":"2016","journal-title":"Vet Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/vde.13286.","article-title":"Long-term use of lokivetmab in dogs with atopic dermatitis","author":"B Kasper","year":"2024","journal-title":"Vet Dermatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1365-3164.2012.01054.x","article-title":"Owner assessment of therapeutic interventions for canine atopic dermatitis: a\n                    long-term retrospective analysis","volume":"23","author":"D L Dell","year":"2012","journal-title":"Vet Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4142\/jvs.2016.17.4.549","article-title":"Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized,\n                    double blind, placebo-controlled trial","volume":"17","author":"Y H Hsiao","year":"2016","journal-title":"J Vet Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/vr.101907","article-title":"Efficacy of dimetinden and hydroxyzine\/chlorpheniramine in atopic dogs: a\n                    randomised, controlled, double-blinded trial","volume":"173","author":"M Eichenseer","year":"2013","journal-title":"Vet Rec"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/s0165-2427(01)00306-3","article-title":"The ACVD task force on canine atopic dermatitis (XXI): antihistamine\n                    pharmacotherapy","volume":"81","author":"D J DeBoer","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-3164.2009.00756.x","article-title":"Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine\n                    atopic dermatitis: a randomised, double blind, placebo-controlled trial","volume":"20","author":"T Nuttall","year":"2009","journal-title":"Vet Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-3164.2004.00397.x","article-title":"Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment\n                    (Protopic) in canine atopic dermatitis: a randomized, double-blinded,\n                    placebo-controlled, cross-over study","volume":"15","author":"R Marsella","year":"2004","journal-title":"Vet Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/inpract.20.5.244","article-title":"Use and abuse of topical dermatological therapy in dogs and cats Part 1. Shampoo\n                    therapy","volume":"20","author":"C Curtis","year":"1998","journal-title":"In Practice"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-3164.2004.00378.x","article-title":"A randomized, controlled study to evaluate the steroid sparing effect of\n                    essential fatty acid supplementation in the treatment of canine atopic\n                    dermatitis","volume":"15","author":"B K Saevik","year":"2004","journal-title":"Vet Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.tvjl.2015.11.012","article-title":"Evaluation of cyclosporine-sparing effects of polyunsaturated fatty acids in the\n                    treatment of canine atopic dermatitis","volume":"210","author":"M R Muller","year":"2016","journal-title":"Vet J"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/vde.13246","article-title":"A placebo-controlled, double-blind study evaluating the effect of orally\n                    administered polyunsaturated fatty acids on the oclacitinib dose for atopic\n                    dogs","volume":"35","author":"L Schafer","year":"2024","journal-title":"Vet Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1748-5827.1995.tb02961.x","article-title":"Additive benefits of EFAs in dogs with atopic dermatitis after partial response\n                    to antihistamine therapy","volume":"36","author":"S Paterson","year":"1995","journal-title":"J Small Anim Pract"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/ani12182377","article-title":"Comparison of the Gut Microbiome between Atopic and Healthy Dogs-Preliminary\n                    Data","volume":"12","author":"A Rostaher","year":"2022","journal-title":"Animals (Basel)"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/s0091-6749(98)70271-4","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO\n                    position paper","volume":"102","author":"J Bousquet","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/vr.106024","article-title":"Allergen-specific immunotherapy in dogs with atopic dermatitis: is owner\n                    compliance the main success-limiting factor?","volume":"187","author":"L Ramio-Lluch","year":"2020","journal-title":"Vet Rec"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-3164.2008.00727.x","article-title":"A review of allergen-specific immunotherapy in human and veterinary\n                    medicine","volume":"20","author":"C Loewenstein","year":"2009","journal-title":"Vet Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/vde.13138","article-title":"A randomised, double-blinded comparison between subcutaneous rush and\n                    intralympathic allergen immunotherapy induction in atopic dogs","volume":"34","author":"R S Mueller","year":"2023","journal-title":"Vet Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/vde.12860","article-title":"A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy\n                    for the long-term control of dogs with nonseasonal atopic dermatitis","volume":"31","author":"N M Fischer","year":"2020","journal-title":"Vet Dermatol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/vde.13075","article-title":"Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective\n                    study of 664 cases","volume":"33","author":"EE M Fennis","year":"2022","journal-title":"Vet Dermatol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0165-2427(01)00304-x","article-title":"The ACVD task force on canine atopic dermatitis (XVI): laboratory evaluation of\n                    dogs with atopic dermatitis with serum-based \"allergy\" tests","volume":"81","author":"D J DeBoer","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/vde.12740","article-title":"Treatment of canine atopic dermatitis: time to revise our strategy","volume":"30","author":"T Olivry","year":"2019","journal-title":"Vet Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/vde.12696","article-title":"Caregiver burden in the veterinary dermatology client: comparison to healthy\n                    controls and relationship to quality of life","volume":"30","author":"M B Spitznagel","year":"2019","journal-title":"Vet Dermatol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/vr.104295","article-title":"Caregiver burden in owners of a sick companion animal: a cross-sectional\n                    observational study","volume":"181","author":"M B Spitznagel","year":"2017","journal-title":"Vet Rec"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/vde.12938","article-title":"Treatment complexity and caregiver burden are linked in owners of dogs with\n                    allergic\/atopic dermatitis","volume":"32","author":"M B Spitznagel","year":"2021","journal-title":"Veterinary Dermatology"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/geront\/20.6.649","article-title":"Relatives of the impaired elderly: correlates of feelings of burden","volume":"20","author":"S H Zarit","year":"1980","journal-title":"Gerontologist"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cvsm.2019.01.008","article-title":"Caregiver Burden and Veterinary Client Well-Being","volume":"49","author":"M B Spitznagel","year":"2019","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-3164.2010.00954.x","article-title":"Quality of life of dogs with skin diseases and their owners. Part 1: development\n                    and validation of a questionnaire","volume":"22","author":"C Noli","year":"2011","journal-title":"Vet Dermatol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tvjl.2018.04.007","article-title":"Predicting caregiver burden in general veterinary clients: Contribution of\n                    companion animal clinical signs and problem behaviors","volume":"236","author":"M B Spitznagel","year":"2018","journal-title":"Vet J"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/vde.13200.","article-title":"Are images worth a thousand words? A preliminary study testing a video for owner\n                    education in canine atopic dermatitis","author":"B Fernandes","year":"2023","journal-title":"Vet Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2460\/javma.2004.225.222","article-title":"Use of the roter interaction analysis system to analyze\n                    veterinarian-client-patient communication in companion animal practice","volume":"225","author":"J R Shaw","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.2460\/javma.233.7.1072","article-title":"A focus group study of veterinarians' and pet owners' perceptions of\n                    veterinarian-client communication in companion animal practice","volume":"233","author":"J B Coe","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/1098612X19858154","article-title":"Priorities on treatment and monitoring of diabetic cats from the owners'\n                    points of view","volume":"22","author":"C S Albuquerque","year":"2020","journal-title":"J Feline Med Surg"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.prevetmed.2018.03.020","article-title":"Motivators and barriers for dog and cat owners and veterinary surgeons in the\n                    United Kingdom to using preventative medicines","volume":"154","author":"Z Belshaw","year":"2018","journal-title":"Prev Vet Med"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-2133.2004.06174.x","article-title":"Better medication adherence results in greater improvement in severity of\n                    psoriasis","volume":"151","author":"C L Carroll","year":"2004","journal-title":"Br J Dermatol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaad.2006.05.073","article-title":"Stealth monitoring of adherence to topical medication: adherence is very poor in\n                    children with atopic dermatitis","volume":"56","author":"J Krejci-Manwaring","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/pde.12045","article-title":"Therapeutic patient education in children with atopic dermatitis: position paper\n                    on objectives and recommendations","volume":"30","author":"S Barbarot","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"ref72","volume-title":"National Library of Medicine Current Bibliographies in Medicine: Health\n                    Literacy","author":"S Ratzan","year":"2000"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1053\/j.tcam.2018.06.002","article-title":"Read All About It: Health Literacy and Veterinary Client Educational\n                    Materials","volume":"33","author":"S A Moore","year":"2018","journal-title":"Topics in Companion Animal Medicine"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2340\/00015555-1022","article-title":"Patient education in chronic skin diseases: a systematic review","volume":"91","author":"J de Bes","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jaad.2010.01.051","article-title":"Online video improves clinical outcomes in adults with atopic dermatitis: a\n                    randomized controlled trial","volume":"64","author":"A W Armstrong","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.2196\/jmir.3035","article-title":"Supporting self-care for families of children with eczema with a Web-based\n                    intervention plus health care professional support: pilot randomized controlled\n                    trial","volume":"16","author":"M Santer","year":"2014","journal-title":"J Med Internet Res"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s001050051337","article-title":"[Intensive patient education and treatment program for young adults with atopic\n                    eczema]","volume":"52","author":"P J Coenraads","year":"2001","journal-title":"Hautarzt"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/bmj.332.7547.933","article-title":"Age related, structured educational programmes for the management of atopic\n                    dermatitis in children and adolescents: multicentre, randomised controlled\n                    trial","volume":"332","author":"D Staab","year":"2006","journal-title":"BMJ"}],"container-title":["Tier\u00e4rztliche Praxis Ausgabe K: Kleintiere \/ Heimtiere"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2712-9246.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T23:50:13Z","timestamp":1764373813000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2712-9246"}},"subtitle":["Spezielle Ber\u00fccksichtigung der Caregiver burden und Lebensqualit\u00e4t\n                    der Hunde und Besitzer*innen"],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":78,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2025,11,28]]},"published-print":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2712-9246","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1434-1239","2567-5842"],"issn-type":[{"value":"1434-1239","type":"print"},{"value":"2567-5842","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}